Cancer and Diagnostics

Cancer Syndrome

Researchers are invited to submit abstracts for the "Cancer Syndrome" track at the "World Cancer 2024" conference, focusing on inherited genetic predispositions to cancer and associated syndromes. Abstracts should highlight novel genetic mutations, hereditary cancer syndromes, and their implications for cancer risk assessment, prevention, and management.

Attendees can expect presentations on the latest discoveries in cancer predisposition genes, genetic testing technologies, and counseling strategies for individuals and families affected by hereditary cancer syndromes. Discussions will cover a wide range of syndromes, including hereditary breast and ovarian cancer syndrome, Lynch syndrome, Li-Fraumeni syndrome, and familial adenomatous polyposis, among others.

The track will also feature sessions on the integration of genetic information into clinical practice, including risk assessment models, surveillance guidelines, and risk-reducing interventions such as prophylactic surgery and chemoprevention. Attendees will have the opportunity to engage with leading experts, share insights, and explore collaborative opportunities to advance our understanding of cancer syndromes and improve patient care.